Uses of DLL3-targeting multispecific antigen-binding molecules
TW202641581APending Publication Date: 2026-10-16CHUGAI PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115121646
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-09-29
- Filing Date
- 2022-09-28
- Publication Date
- 2026-10-16
Smart Images
Figure 00000000_0000_ABST
Abstract
The disclosure provides uses of multispecific antigen-binding molecules that targets human DLL3 for the treatment of cancers.
Need to check novelty before this filing date? Find Prior Art